Skip to main content
. 2023 May 5;15(9):2626. doi: 10.3390/cancers15092626

Figure 5.

Figure 5

c-Met in cancer cells drives tumor-associated neutrophil remodeling (A) qPCR analyses of N2 neutrophil markers in mouse neutrophils treated with indicated CM. (B) N2 neutrophil markers were quantified by qPCR in mouse neutrophils treated with indicated CM (C) Principal Analysis of RNA sequencing data of neutrophils treated with indicated CM. (D) Heatmap of key neutrophils external proteins from RNA sequencing (* p  <  0.05, ** p  <  0.01, or *** p < 0.001).